190 related articles for article (PubMed ID: 34398437)
1. Impact of repeated co-treatment with escitalopram and aripiprazole on the schizophrenia-like behaviors and BDNF mRNA expression in the adult Sprague-Dawley rats exposed to glutathione deficit during early postnatal development of the brain.
Lech MA; Kamińska K; Leśkiewicz M; Lorenc-Koci E; Rogóż Z
Pharmacol Rep; 2021 Dec; 73(6):1712-1723. PubMed ID: 34398437
[TBL] [Abstract][Full Text] [Related]
2. Repeated co-treatment with mirtazapine and aripiprazole reversed the schizophrenia-like behaviors and increased the brain-derived neurotrophic factor mRNA expression in the adult Sprague-Dawley rats exposed to glutathione deficit during early postnatal brain development.
Lech MA; Kaminska K; Wasik A; Lorenc-Koci E; Rogoz Z
J Physiol Pharmacol; 2021 Oct; 72(5):. PubMed ID: 35158332
[TBL] [Abstract][Full Text] [Related]
3. Glutathione Deficiency during Early Postnatal Development Causes Schizophrenia-Like Symptoms and a Reduction in BDNF Levels in the Cortex and Hippocampus of Adult Sprague-Dawley Rats.
Lech MA; Leśkiewicz M; Kamińska K; Rogóż Z; Lorenc-Koci E
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201038
[TBL] [Abstract][Full Text] [Related]
4. N-Acetylcysteine and Aripiprazole Improve Social Behavior and Cognition and Modulate Brain BDNF Levels in a Rat Model of Schizophrenia.
Rogóż Z; Kamińska K; Lech MA; Lorenc-Koci E
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216241
[TBL] [Abstract][Full Text] [Related]
5. Co-treatment with antidepressants and aripiprazole reversed the MK-801-induced some negative symptoms of schizophrenia in rats.
Hereta M; Kamińska K; Rogóż Z
Pharmacol Rep; 2019 Oct; 71(5):768-773. PubMed ID: 31351318
[TBL] [Abstract][Full Text] [Related]
6. An animal model with relevance to schizophrenia: sex-dependent cognitive deficits in osteogenic disorder-Shionogi rats induced by glutathione synthesis and dopamine uptake inhibition during development.
Castagné V; Cuénod M; Do KQ
Neuroscience; 2004; 123(4):821-34. PubMed ID: 14751276
[TBL] [Abstract][Full Text] [Related]
7. Treatment with aripiprazole and N-acetylcysteine affects anaerobic cysteine metabolism in the hippocampus and reverses schizophrenia-like behavior in the neurodevelopmental rat model of schizophrenia.
Górny M; Bilska-Wilkosz A; Iciek M; Rogóż Z; Lorenc-Koci E
FEBS J; 2023 Dec; 290(24):5773-5793. PubMed ID: 37646112
[TBL] [Abstract][Full Text] [Related]
8. Glutathione Deficiency and Alterations in the Sulfur Amino Acid Homeostasis during Early Postnatal Development as Potential Triggering Factors for Schizophrenia-Like Behavior in Adult Rats.
Górny M; Wnuk A; Kamińska A; Kamińska K; Chwatko G; Bilska-Wilkosz A; Iciek M; Kajta M; Rogóż Z; Lorenc-Koci E
Molecules; 2019 Nov; 24(23):. PubMed ID: 31766654
[TBL] [Abstract][Full Text] [Related]
9. Effect of combined treatment with aripiprazole and antidepressants on the MK-801-induced deficits in recognition memory in novel recognition test and on the release of monoamines in the rat frontal cortex.
Hereta M; Kamińska K; Białoń M; Wąsik A; Lorenc-Koci E; Rogóż Z
Behav Brain Res; 2020 Sep; 393():112769. PubMed ID: 32535184
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Glutathione Deficit During Early Postnatal Brain Development on the Prepulse Inhibition and Monoamine Levels in Brain Structures of Adult Sprague-Dawley Rats.
Rogóż Z; Lech MA; Chamera K; Wąsik A
Neurotox Res; 2022 Jun; 40(3):733-750. PubMed ID: 35386024
[TBL] [Abstract][Full Text] [Related]
11. The combination of escitalopram and aripiprazole: Investigation of psychomotor effects in rats.
Hudson R; Zhou Y; Leri F
J Psychopharmacol; 2017 Dec; 31(12):1605-1614. PubMed ID: 29069975
[TBL] [Abstract][Full Text] [Related]
12. Time-dependent effects of escitalopram on brain derived neurotrophic factor (BDNF) and neuroplasticity related targets in the central nervous system of rats.
Alboni S; Benatti C; Capone G; Corsini D; Caggia F; Tascedda F; Mendlewicz J; Brunello N
Eur J Pharmacol; 2010 Sep; 643(2-3):180-7. PubMed ID: 20599917
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment with aripiprazole and antidepressants reversed some MK-801-induced schizophrenia-like symptoms in mice.
Rogóż Z; Wąsik A; Lorenc-Koci E
Pharmacol Rep; 2018 Aug; 70(4):623-630. PubMed ID: 29885435
[TBL] [Abstract][Full Text] [Related]
14. Repeated administration of aripiprazole produces a sensitization effect in the suppression of avoidance responding and phencyclidine-induced hyperlocomotion and increases D2 receptor-mediated behavioral function.
Gao J; Qin R; Li M
J Psychopharmacol; 2015 Apr; 29(4):390-400. PubMed ID: 25586399
[TBL] [Abstract][Full Text] [Related]
15. Low brain glutathione and ascorbic acid associated with dopamine uptake inhibition during rat's development induce long-term cognitive deficit: relevance to schizophrenia.
Castagné V; Rougemont M; Cuenod M; Do KQ
Neurobiol Dis; 2004 Feb; 15(1):93-105. PubMed ID: 14751774
[TBL] [Abstract][Full Text] [Related]
16. Chronic clozapine treatment improves the alterations of prepulse inhibition and BDNF mRNA expression in the medial prefrontal cortex that are induced by adolescent social isolation.
Li M; Wang W; Sun L; Du W; Zhou H; Shao F
Behav Pharmacol; 2019 Jun; 30(4):311-319. PubMed ID: 30157036
[TBL] [Abstract][Full Text] [Related]
17. The dopamine D₃-preferring D₂/D₃ dopamine receptor partial agonist, cariprazine, reverses behavioural changes in a rat neurodevelopmental model for schizophrenia.
Watson DJG; King MV; Gyertyán I; Kiss B; Adham N; Fone KCF
Eur Neuropsychopharmacol; 2016 Feb; 26(2):208-224. PubMed ID: 26723167
[TBL] [Abstract][Full Text] [Related]
18. WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol-2(3H)-one]: a novel dopamine D2 receptor partial agonist/serotonin reuptake inhibitor with preclinical antipsychotic-like and antidepressant-like activity.
Brennan JA; Graf R; Grauer SM; Navarra RL; Pulicicchio CM; Hughes ZA; Lin Q; Wantuch C; Rosenzweig-Lipson S; Pruthi F; Lai M; Smith D; Goutier W; van de Neut M; Robichaud AJ; Rotella D; Feenstra RW; Kruse C; Broqua P; Beyer CE; McCreary AC; Pausch MH; Marquis KL
J Pharmacol Exp Ther; 2010 Jan; 332(1):190-201. PubMed ID: 19828876
[TBL] [Abstract][Full Text] [Related]
19. The effect of combined treatment with escitalopram and risperidone on the MK-801-induced changes in the object recognition test in mice.
Rogóż Z; Kamińska K
Pharmacol Rep; 2016 Feb; 68(1):116-20. PubMed ID: 26721362
[TBL] [Abstract][Full Text] [Related]
20. Repeated co-treatment with antidepressants and risperidone increases BDNF mRNA and protein levels in rats.
Rogóż Z; Kamińska K; Pańczyszyn-Trzewik P; Sowa-Kućma M
Pharmacol Rep; 2017 Oct; 69(5):885-893. PubMed ID: 28624596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
